Kwee Yong Selected Research

Kwee Yong Research Topics

Disease

73	Multiple Myeloma 03/2024 - 10/2002
9	Neoplasms (Cancer) 01/2024 - 11/2002
7	Residual Neoplasm 03/2024 - 01/2016
7	Infections 02/2023 - 06/2002
7	Immunoglobulin Light-chain Amyloidosis 01/2022 - 01/2018
6	Disease Progression 03/2024 - 07/2016
5	Peripheral Nervous System Diseases (PNS Diseases) 01/2023 - 05/2013
4	Thrombocytopenia (Thrombopenia) 01/2021 - 07/2014
4	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2014 - 02/2002
3	Hypertension (High Blood Pressure) 02/2023 - 01/2020
3	Lymphopenia (Lymphocytopenia) 02/2023 - 03/2003
3	Amyloidosis 10/2022 - 01/2020
3	Cytomegalovirus Infections (Inclusion Disease) 03/2011 - 06/2002
2	COVID-19 09/2022 - 01/2022
2	Fatigue 05/2021 - 10/2014
2	Necrosis 12/2018 - 01/2014
2	Neutropenia 01/2017 - 07/2014
1	Chromosome Aberrations (Chromosome Abnormalities) 03/2024
1	Paraproteinemias (Monoclonal Gammopathy) 02/2024
1	Monoclonal Gammopathy of Undetermined Significance 03/2023
1	Cytopenia 01/2023
1	Cytokine Release Syndrome 01/2023
1	cell-associated neurotoxicity 01/2023
1	Bone Diseases (Bone Disease) 12/2022
1	Chronic Disease (Chronic Diseases) 05/2021
1	Plasmacytoma 05/2021
1	Thrombosis (Thrombus) 01/2021
1	Hemolytic Anemia 01/2021
1	Thrombotic Microangiopathies 01/2021
1	Smoldering Multiple Myeloma 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Cross Infection (Nosocomial Infection) 12/2019
1	Tendinopathy (Tendonitis) 12/2019
1	Inflammation (Inflammations) 11/2019

Drug/Important Bio-Agent (IBA)

26	Dexamethasone (Maxidex)FDA LinkGeneric 03/2024 - 10/2014
17	Bortezomib (Velcade)FDA Link 02/2023 - 05/2013
16	carfilzomibIBA 03/2024 - 01/2016
13	isatuximabIBA 03/2024 - 01/2020
8	Lenalidomide (CC 5013)FDA Link 07/2023 - 01/2015
8	Melphalan (Alkeran)FDA LinkGeneric 07/2023 - 02/2002
8	Proteasome InhibitorsIBA 02/2022 - 03/2018
7	Monoclonal AntibodiesIBA 12/2022 - 09/2020
7	Alemtuzumab (Campath)FDA Link 01/2014 - 02/2002
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2023 - 07/2014
5	AntigensIBA 06/2021 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2021
4	Chimeric Antigen ReceptorsIBA 01/2024 - 01/2018
4	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 07/2023 - 01/2018
4	daratumumabIBA 01/2023 - 01/2018
4	pomalidomideIBA 12/2021 - 01/2017
4	PanobinostatIBA 12/2020 - 10/2014
3	B-Cell Maturation AntigenIBA 07/2023 - 01/2018
3	belantamab mafodotinIBA 01/2022 - 12/2018
3	ixazomibIBA 01/2021 - 03/2018
3	Thalidomide (Thalomid)FDA Link 01/2019 - 12/2016
2	Bispecific AntibodiesIBA 01/2024 - 01/2023
2	Biomarkers (Surrogate Marker)IBA 03/2023 - 12/2017
2	Antiviral Agents (Antivirals)IBA 01/2023 - 12/2002
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2020
2	Levofloxacin (Levaquin)FDA Link 12/2019 - 11/2019
2	Alkylating AgentsIBA 12/2018 - 05/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2018 - 07/2016
2	CyclinsIBA 01/2011 - 04/2010
2	fludarabineIBA 12/2002 - 02/2002
1	Adenosine Monophosphate (AMP)IBA 03/2024
1	Surface Antigens (Surface Antigen)IBA 01/2024
1	CreatinineIBA 03/2023
1	tocilizumab (atlizumab)FDA Link 01/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	ceramide glucosyltransferaseIBA 12/2022
1	eliglustatIBA 12/2022
1	TNF Receptor-Associated Factor 3IBA 12/2022
1	Diphosphonates (Bisphosphonates)IBA 12/2022
1	Zoledronic Acid (Zometa)FDA Link 12/2022
1	GlycosphingolipidsIBA 12/2022
1	antineoplaston A10 (A 10)IBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2019
1	monomethylauristatin FIBA 12/2018
1	Cell Surface ReceptorsIBA 12/2018
1	Immunoconjugates (Immunoconjugate)IBA 12/2018
1	Immunologic Factors (Immunomodulators)IBA 12/2018
1	RNA (Ribonucleic Acid)IBA 11/2018
1	Bendamustine Hydrochloride FDA Link 05/2018
1	Proteasome Endopeptidase Complex (Proteasome)IBA 03/2018
1	Single-Chain AntibodiesIBA 01/2018

Therapy/Procedure

26	Therapeutics 03/2024 - 12/2002
23	Stem Cell Transplantation 01/2024 - 06/2002
7	Transplantation 02/2023 - 06/2002
6	Drug Therapy (Chemotherapy) 09/2022 - 04/2003
2	Premedication 01/2023 - 01/2021
2	Preoperative Exercise 01/2022 - 01/2020
2	Antibiotic Prophylaxis 12/2019 - 11/2019
1	Immunotherapy 01/2024
1	Treatment Delay 09/2022
1	Ambulatory Care (Outpatient Care) 06/2021
1	Salvage Therapy 01/2021
1	Aftercare (After-Treatment) 01/2021
1	Drug Tapering 01/2017